- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GeoVax Labs Inc (GOVX)
GeoVax Labs Inc stock price live, this page displays NASDAQ GOVX stock exchange data. View the GOVX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the GeoVax Labs Inc real time stock price chart below.
What Is the GeoVax Labs Inc Stock Price Today?
The GeoVax Labs Inc stock price today is 0.4511.
What Is the Stock Symbol for GeoVax Labs Inc?
The stock symbol for GeoVax Labs Inc is ""GOVX.""
What Stock Exchange Does GeoVax Labs Inc Trade On?
GeoVax Labs Inc is listed and trades on the NASDAQ stock exchange.
Is GeoVax Labs Inc a Good Stock to Buy?
Determining whether GeoVax Labs Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GOVX quote. (ISIN: US3736786068)
What Is the GeoVax Labs Inc Stock Price Today?
The GeoVax Labs Inc stock price today is 0.4511.
What Is the Stock Symbol for GeoVax Labs Inc?
The stock symbol for GeoVax Labs Inc is ""GOVX.""
What Stock Exchange Does GeoVax Labs Inc Trade On?
GeoVax Labs Inc is listed and trades on the NASDAQ stock exchange.
Is GeoVax Labs Inc a Good Stock to Buy?
Determining whether GeoVax Labs Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GOVX quote. (ISIN: US3736786068)
NASDAQ
Currency in USD
Fair Value
An estimate of a GeoVax Labs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.4150
0.4598
52 wk Range
0.4150
3.1500
Trading near 52-week Low
1/2
Fair Value
An estimate of a GeoVax Labs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.41500.4598
52 wk Range
0.41503.1500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GOVX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a GeoVax Labs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
10.3750
Upside
+2,199.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
GeoVax Labs Inc Company Profile
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. It also developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.
GeoVax Labs Inc Earnings Call Summary for Q3/2025
- GeoVax reported Q3 2025 revenue of $2.5 million, down from $3.1 million YoY, with stock falling 5.8% in regular trading but recovering 1.1% after hours
- R&D expenses decreased to $5 million from $7.4 million, while nine-month net loss increased to $17 million from $16.7 million; cash balance fell to $5 million
- The company is advancing its GEO-MVA vaccine to clinical evaluation and progressing CM04S1 COVID-19 vaccine specifically targeting immunocompromised populations
- Management forecasts Q4 2025 EPS of -0.2 USD and FY 2025 EPS of -0.9 USD, while CEO David Dodd expressed confidence in building 'significant shareholder value'
Last Updated: 13/11/2025, 23:36
Read Full TranscriptCompare GOVX to Peers and Sector
Metrics to compare | GOVX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGOVXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −2.5x | −0.6x | |
PEG Ratio | −0.01 | −0.14 | 0.00 | |
Price/Book | 2.7x | 1.0x | 2.6x | |
Price / LTM Sales | 4.0x | 17.7x | 3.3x | |
Upside (Analyst Target) | - | 228.2% | 41.7% | |
Fair Value Upside | Unlock | 9.1% | 5.1% | Unlock |
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 10.3750
(+2,199.93% Upside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.31 / -0.29
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the GeoVax Labs (GOVX) Premarket Price Today?
The GeoVax Labs (GOVX) premarket price is 0.4162. Premarket price change units: -0.0528. Premarket percentage change: -11.2600%. Premarket volume: 125,060.0000. Current date: 16 Nov 2025. Previous close: 0.4690
What Stock Exchange Does GeoVax Labs Trade On?
GeoVax Labs is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for GeoVax Labs?
The stock symbol for GeoVax Labs is "GOVX."
What Is the GeoVax Labs (GOVX) Afterhours Price Today? (Afterhours variable test: 0.4502) Current Date: 16 Nov 2025
After hours price: 0.4502. After hours price change (units): -0.0009. Price change percentage: -0.2000%
What Is the GeoVax Labs Market Cap?
As of today, GeoVax Labs market cap is 13.40M.
What Is GeoVax Labs's Earnings Per Share (TTM)?
The GeoVax Labs EPS (TTM) is -1.63.
From a Technical Analysis Perspective, Is GOVX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has GeoVax Labs Stock Split?
GeoVax Labs has split 5 times.
How Many Employees Does GeoVax Labs Have?
GeoVax Labs has 17 employees.
What is the current trading status of GeoVax Labs (GOVX)?
As of 16 Nov 2025, GeoVax Labs (GOVX) is trading at a price of 0.4511, with a previous close of 0.4690. The stock has fluctuated within a day range of 0.4150 to 0.4598, while its 52-week range spans from 0.4150 to 3.1500.
What Is GeoVax Labs (GOVX) Price Target According to Analysts?
The average 12-month price target for GeoVax Labs is USD10.375, with a high estimate of USD14 and a low estimate of USD8.5. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +2,199.93% Upside potential.
What Is the GOVX Premarket Price?
GOVX's last pre-market stock price is 0.4162. The pre-market share volume is 125,060.0000, and the stock has decreased by -0.0528, or -11.2600%.
What Is the GOVX After Hours Price?
GOVX's last after hours stock price is 0.4502, the stock has decreased by -0.0009, or -0.2000%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.